Sanofi initiated at neutral at Goldman Sachs on need to see pipeline successes

mbbirdy Goldman Sachs has initiated Sanofi ( NASDAQ: SNY ) at neutral, saying that while the French pharma is "emerging as a pipeline story," the firm needs to see more data from candidates before becoming more positive. The investment bank has a $65 price target (~13% upside.